Module 11 Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

***** which of these are bacterial infections for which there are NO vaccines?

a - mycobacterium tuberculosis
b - corneybacterium diptheria
c - staphylococcus aureua
d - streptococcus pneumoniae
e - streptococcus pyogenes
f - C & E

A

f - C & E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the genus Neisseria a pathogen of

A

respiratory & genital tracts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

members of the genus neisseria are __

A

Gram - diplococci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

T/F humans are the only known reservoir for Neisseria pathogens

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

are neisseria pathogens catalase positive or negative

A

positive –> obligate aerobes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the main species of the Neisseria genus

A
  • N. meningitidis (meningitis)
  • N. gonorrhoeae (gonorrhea)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is closely related to Neisseria and is the normal flora of the upper respiratory tract

A

Moraxella catarrhalis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

which neisseria pathogen can go septic increasing the inflammation throughout the body

A

meningitidis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

which neisseria pathogen is only able to inhabit mucosal surfaces

A

gonorrhoeae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is important in the transmission of neisseria pathogens

A

the carrier state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the susceptible age group for N. meningitidis

A

15 - 24

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how is N. meningitidis transmitted

A

large respiratory droplets in close range

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the significant morality rate of N. meningitidis

A

10-15% even w/ antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

after _ days in the carrier phase the disease state either stops as a _ or transitions to _ or _

A
  • 10
  • minor carrier
  • sepsis / meningo-sepsis
  • meningitis residing in the spinal cord
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how is gonorrhea transmitted

A

spread ONLY by direct genital contact attaching to epithelial cells in the urethra and cervix and remains localized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the symptoms of N. gonorrhea

A

inflammation, yellow discharge, pelvic inflammatory disease (PID)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what does N. gonorrhea have drug resistance to

A

beta-lactams & tetracyclines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how is N. gonorrhea diagnosed

A

Gram stain –> Gram - diplococcus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is the spread of large numbers of N. meningitidis in the bloodstream via lymphatic system causing sepsis and LPS/LOS endotxoin shock

A

meningococcemia

20
Q

how does meningococcemia proceed to meningitis

A

inflammation spreads to the meninges via choroid plexus

21
Q

what are the neurological defects that meningitis can cause

A
  • neuromotor disabilities
  • seizure disorders
  • learning difficulties
22
Q

what are the virulence factors of N. meningitidis

A
  • variant LPS in cell envelope (no O-antigen)
  • endotoxins that are cytotoxic
  • pili (fimbriae)
  • exo-enzymes (IgA1 protease)
23
Q

what virulence factor is used for the N. meningitidis vaccine

A

the polysaccharide capsule

24
Q

what is the function of IgA1

A

protect against IgA1 on mucosal surfaces and aids in colonization

25
Q

what are the treatment options for N. meningitidis infections

A
  • antibiotics (Penicllin G, but typically not enough on is own)
  • steroids (reduces inflammation)
26
Q

___ has the largest problem with bacterial A strains of N. meningitidis

A

africa

27
Q

what do all Gram - bacteria release

A

‘blebs’ or outer membrane vesicles

28
Q

how do you prevent N. menigitidis

A

vaccines

29
Q

what are the vaccines for N. meningitidis

A
  • A/C/Y/W-135 (Menomune)
  • ‘B’ strain
  • ACY/W conjugate vaccine (Menactra)
  • 4CMenB
30
Q

Menomunes use was restricted to to

A

military

31
Q

Menomune works well in __ but has no response in ___

A

adults, children < 2 years old

32
Q

how does ACY/W vaccine Menomune work

A

purified capsule polysaccharide

33
Q

how does ACY/W Conjugate vaccine Menactra work

A

purified capsule polysaccharide conjugated to protein (diptheria toxoid)

34
Q

the US now sees mostly type __ strains of N. meningitidis

A

B

35
Q

what is the appearance of the haemophilus genus

A

small Gram - coccobacilli

36
Q

Haemophilus are a a major part of the normal flora of the __

A

URT

37
Q

how does H. influenzae spread

A

via inhalation of airborne droplets, shared secretions, etc.

38
Q

non-invasive infections usually originate from __

A

existing normal flora strains of H. influenzae that do NOT have a capsule

39
Q

what are infections that H. influenzae can cause

A
  • sinusitis
  • pink eye
  • pneumonia
40
Q

what are invasive infections that H. influenzae can cause

A
  • septicemia
  • meningitis
41
Q

what are the symptoms and syndromes of septicemia

A
  • disseminated intravascular coagulation (DIC)
  • septic shock
  • death
42
Q

what are H. influenzaes virulence factors

A
  • cellular envelope w/ LPS (LOS) no O-antigen
  • endotoxin
  • cytotoxic
  • inflammatory
  • capsule
  • exoenzymes (IgA protease)
43
Q

what is the first conjugate vaccine for H. influenzae

A

type b capsule covalently linked to a protein (diphtheria toxoid & tetanus toxoid)

44
Q

why are these pathogens considered “triplets”

A

respiratory, encapsulated –> bloodstream –> meningitis

45
Q
A